Relationship of Opening CSF Pressure and Visual Field Defect in Idiopathic Intracranial Hypertension
International Clinical Neuroscience Journal,
Vol. 5 No. 2 (2018),
19 June 2018
Background: Idiopathic intracranial hypertension (IIH) is an increased intracranial pressure with normal cerebrospinal fluid (CSF) characteristic in the absence of identifiable causes. The most important complication of this disorder is visual impairment. So far, no comprehensive study has been done on the relationship between the opening CSF pressure and visual field defect in IIH.
Methods: In this study, 35 patients with increased intracranial pressure who fulfilled modified Dandy’s criteria underwent ophthalmologic examination and lumbar puncture. The opening CSF pressure was categorized into mild (25-30), moderate (30-40) and severe (>40). The degree of visual field defect was reported both quantitatively and qualitatively. Eventually, the statistical relationship was established among these variables.
Results: The mean opening CSF pressure was 33.71 CmH2o. Twelve patients had minor CSF pressure, whereas in 14 and 9 patients the CSF pressure was respectively moderate and severe. There was not statistically significant relationship between the visual field defect and CSF pressure. The most common patterns of visual field involvement were enlarged blind spot and peripheral restriction.
Conclusion: The most important morbidity in IIH is visual impairment. According to the findings, the visual field impairment is not pertinent to CSF pressure. In other words, neither high CSF pressure predicts intense visual defect, nor low CSF pressure indicates minimal visual impairment.
- Idiopathic intracranial hypertension (IIH)
- Visual field
- CSF pressure
How to Cite
Digre KB, Nakamoto BK, Warner JE, Langeberg WJ, Baggaley SK, Katz BJ. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache: The Journal of Head and Face Pain. 2009;49(2):185-93.
Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159-65. Epub 2013/08/24.
Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Archives of neurology. 1988;45(8):875-7. Epub 1988/08/01.
Sorensen PS, Krogsaa B, Gjerris F. Clinical course and prognosis of pseudotumor cerebri. A prospective study of 24 patients. Acta neurologica Scandinavica. 1988;77(2):164-72. Epub 1988/02/01.
Baheti NN, Nair M, Thomas SV. Long-term visual outcome in idiopathic intracranial hypertension. Annals of Indian Academy of Neurology. 2011;14(1):19-22. Epub 2011/06/03.
Eissa EM, Daker LI, Shaban MM, Hegazy MI. Lumbar puncture as a single modality for treatment of idiopathic intracranial hypertension during pregnancy. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2016;53(1):33.
Craig JJ, Mulholland DA, Gibson JM. Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991-1995). The Ulster medical journal. 2001;70(1):31-5. Epub 2001/06/29.
Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA neurology. 2014;71(6):693-701. Epub 2014/04/24.
Wall M. Idiopathic intracranial hypertension (Pseudotumor cerebri). Current Neurology and Neuroscience Reports. 2008;8(2):87-93.
Thurtell MJ, Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Current treatment options in neurology. 2013;15(1):1-12.
Thurtell MJ, Bruce BB, Newman NJ, Biousse V. An update on idiopathic intracranial hypertension. Reviews in neurological diseases. 2010;7(2-3):e56-68. Epub 2010/10/15.
Jensen RH, Radojicic A, Yri H. The diagnosis and management of idiopathic intracranial hypertension and the associated headache. Therapeutic advances in neurological disorders. 2016;9(4):317-26. Epub 2016/07/02.
Wall M. The importance of visual field testing in idiopathic intracranial hypertension. Continuum (Minneapolis, Minn). 2014;20(4 Neuro-ophthalmology):1067-74. Epub 2014/08/08.
Fisayo A, Bruce BB, Newman NJ, Biousse V. Overdiagnosis of idiopathic intracranial hypertension. Neurology. 2016;86(4):341-50.
Saindane AM, Bruce BB, Riggeal BD, Newman NJ, Biousse V. Association of MRI findings and visual outcome in idiopathic intracranial hypertension. AJR American journal of roentgenology. 2013;201(2):412-8. Epub 2013/07/26.
El-Saadany WF, Farhoud A, Zidan I. Lumboperitoneal shunt for idiopathic intracranial hypertension: patients' selection and outcome. Neurosurgical review. 2012;35(2):239-43; discussion 43-4. Epub 2011/10/01.
Soiberman U, Stolovitch C, Balcer LJ, Regenbogen M, Constantini S, Kesler A. Idiopathic intracranial hypertension in children: visual outcome and risk of recurrence. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 2011;27(11):1913-8. Epub 2011/05/04.
- Abstract Viewed: 446 times
- PDF Downloaded: 440 times